Brian Dougherty PhD, MBA

Brian Dougherty is the director of Translational Genomics Oncology at AstraZeneca Pharmaceuticals in Waltham, MA. He oversees a team of lab scientists and computational biologists applying leading-edge genetic, genomic, and advanced algorithmic technologies to deliver on Precision Medicine – matching the right patient with the right drug. AstraZeneca’s Irish subsidiary, based in Co. Dublin is instrumental in the company’s operations.

In 2015, Brian received the AstraZeneca CEO Award and the IMed Science Team Award. He worked on the cross-functional teams that brought new therapies to cancer patients such as Lynpara for ovarian cancer (2014) and Tigris for lung cancer (2015). He holds a B.A. from the University of Delaware, a Ph.D. from Wake Forest University Medical Center, an M.B.A from the University of New Haven, and completed a postdoctoral research fellowship in the laboratory of Nobel laureate Hamilton O. Smith at The Johns Hopkins University School of Medicine.